Benin has successfully stopped mass drug administration (MDA) for lymphatic filariasis in the country following the likely interruption of transmission in all 48 endemic districts as of FY21 (October 2020 – September 2021).
Benin was validated by the WHO as having eliminated trachoma as a public health problem in May 2023.
Benin's NTDP is considering accelerating OV elimination by shifting from one-a-year to twice-a-year MDA in selected areas. The NOEC will review and determine the feasibility of the twice-a-year strategy.
Between 2022 and 2024 Benin has re-evaluated schistosomiasis/soil-transmitted helminthiasis (SCH/STH) in 41 out of 75 districts. The results showed after multiple rounds of MDA, SCH and STH infection had significantly reduced since baseline and the country is moving to a more focused sub-district treatment strategy. Benin were also the first country to conduct integrated TAS (for lymphatic filariasis)/SCH/STH surveys in 2023.
Standard Disease-Specific Indicators as of FY21
FY21 is October 2020 through September 2021
of ever-endemic districts have stopped mass drug administration (MDA) as of FY21
(i.e. have passed stop MDA survey, TAS1 (First Transmission Assessment Survey))*
*MDA has stopped in all districts in Benin
of ever-endemic districts in post-surveillance phase as of FY21
(i.e. have passed last surveillance survey, TAS3 (third Transmission Assessment Survey))
of persons no longer at risk as of FY21 among those who were ever at risk
Benin, which received support from USAID through the ENVISION and Act | West programs, was validated by WHO as having eliminated trachoma as a public health problem in May 2023.
of ever endemic districts have been treated at least once as of FY21
(in cases where a country has more treated districts reported than, ever endemic, the adjusted percent is 100%)